BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li CW, Chang PY, Chen BS. Investigating the mechanism of hepatocellular carcinoma progression by constructing genetic and epigenetic networks using NGS data identification and big database mining method. Oncotarget 2016;7:79453-73. [PMID: 27821810 DOI: 10.18632/oncotarget.13100] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Thiruvengadam M, Venkidasamy B, Subramanian U, Samynathan R, Ali Shariati M, Rebezov M, Girish S, Thangavel S, Dhanapal AR, Fedoseeva N, Lee J, Chung IM. Bioactive Compounds in Oxidative Stress-Mediated Diseases: Targeting the NRF2/ARE Signaling Pathway and Epigenetic Regulation. Antioxidants (Basel) 2021;10:1859. [PMID: 34942962 DOI: 10.3390/antiox10121859] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
2 Chiang AWT, Baghdassarian HM, Kellman BP, Bao B, Sorrentino JT, Liang C, Kuo CC, Masson HO, Lewis NE. Systems glycobiology for discovering drug targets, biomarkers, and rational designs for glyco-immunotherapy. J Biomed Sci 2021;28:50. [PMID: 34158025 DOI: 10.1186/s12929-021-00746-2] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
3 Si H, Wang H, Xiao H, Fang Y, Wu Z. Anti-Tumor Effect of Celastrol on Hepatocellular Carcinoma by the circ_SLIT3/miR-223-3p/CXCR4 Axis. Cancer Manag Res 2021;13:1099-111. [PMID: 33574707 DOI: 10.2147/CMAR.S278023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
4 Fu H, Archer KJ. High-dimensional variable selection for ordinal outcomes with error control. Brief Bioinform 2021;22:334-45. [PMID: 32031572 DOI: 10.1093/bib/bbaa007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Yeh SJ, Chang CA, Li CW, Wang LH, Chen BS. Comparing progression molecular mechanisms between lung adenocarcinoma and lung squamous cell carcinoma based on genetic and epigenetic networks: big data mining and genome-wide systems identification. Oncotarget 2019;10:3760-806. [PMID: 31217907 DOI: 10.18632/oncotarget.26940] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
6 Shen S, Dean DC, Yu Z, Duan Z. Role of cyclin-dependent kinases (CDKs) in hepatocellular carcinoma: Therapeutic potential of targeting the CDK signaling pathway. Hepatol Res 2019;49:1097-108. [PMID: 31009153 DOI: 10.1111/hepr.13353] [Cited by in F6Publishing: 14] [Reference Citation Analysis]
7 Vrecko S, Guenat D, Mercier-Letondal P, Faucheu H, Dosset M, Royer B, Galaine J, Boidot R, Kim S, Jary M, Adotévi O, Borg C, Godet Y. Personalized identification of tumor-associated immunogenic neoepitopes in hepatocellular carcinoma in complete remission after sorafenib treatment. Oncotarget 2018;9:35394-407. [PMID: 30459932 DOI: 10.18632/oncotarget.26247] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
8 Lou Z, Gong YQ, Zhou X, Hu GH. Low expression of miR-199 in hepatocellular carcinoma contributes to tumor cell hyper-proliferation by negatively suppressing XBP1. Oncol Lett 2018;16:6531-9. [PMID: 30405792 DOI: 10.3892/ol.2018.9476] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
9 Zhou ZQ, Zhao JJ, Chen CL, Liu Y, Zeng JX, Wu ZR, Tang Y, Zhu Q, Weng DS, Xia JC. HUS1 checkpoint clamp component (HUS1) is a potential tumor suppressor in primary hepatocellular carcinoma. Mol Carcinog 2019;58:76-87. [PMID: 30182378 DOI: 10.1002/mc.22908] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
10 Concetti J, Wilson CL. NFKB1 and Cancer: Friend or Foe? Cells 2018;7:E133. [PMID: 30205516 DOI: 10.3390/cells7090133] [Cited by in Crossref: 35] [Cited by in F6Publishing: 42] [Article Influence: 8.8] [Reference Citation Analysis]
11 Sheu CC, Tsai MJ, Chen FW, Chang KF, Chang WA, Chong IW, Kuo PL, Hsu YL. Identification of novel genetic regulations associated with airway epithelial homeostasis using next-generation sequencing data and bioinformatics approaches. Oncotarget 2017;8:82674-88. [PMID: 29137293 DOI: 10.18632/oncotarget.19752] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
12 Takagi K, Takayama T, Midorikawa Y, Hasegawa H, Ochiai T, Moriguchi M, Higaki T, Soma M, Nagase H, Fujiwara K. Cell division cycle 34 is highly expressed in hepatitis C virus-positive hepatocellular carcinoma with favorable phenotypes. Biomed Rep 2017;7:41-6. [PMID: 28685058 DOI: 10.3892/br.2017.912] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]